Hba1c Clinical Biochemical Diagnostic Reagent - China

This reagent is used to quantitatively detect the content of glycosylated hemoglobin in human whole blood in vitro.

Background of Clinical Indications

It is used for the auxiliary diagnosis of diabetes and other diseases.

It can reflect the glucose metabolism status of diabetic patients within 2 months.

It can be used as an indicator for monitoring the condition of diabetes, as well as an indicator for early diagnosis of mild, type II, and "hidden" diabetes; it can evaluate the occurrence and development of chronic complications of diabetes.

Company Contact:

• Posted By: Zhejiang Kangte BIO-TECH ,CO.,LTD

• Phone: +86 57182806010

• Address: No.2, Tiequanshan Road, Shaoxing , China

• Email:

• Website: https://www.zjkangte.com/

• Business Description: Zhejiang Xinchang Provincial High-tech Industrial Park.
  
  It is a national high-tech enterprise integrating R&D, production and sales of in vitro diagnostic reagents.
  
  Relying on the pioneering team spirit and scientific management, the company has repeatedly won the national advanced production unit in the in vitro diagnostic industry.
  
  The company has GMP standard workshops, clean workshops, R&D laboratories, equipped with high-precision testing equipment and fully automatic production equipment.
  
  In order to enhance the company's overall R&D strength, it has established a good "production-study-researc h" cooperative relationship with many colleges and universities.
  
  The company has obtained a number of invention patents and utility model patents and has passed ISO9001, ISO14001, ISO13485, and other system certifications.
  
  The company currently has more than 100 registered products, covering biochemical, immunological, and other fields, and many of the products have reached the leading domestic level in technology.
  
  The company adheres to the concept of "integrity, professionalism, efficiency and innovation" to serve customers, and constantly introduces products with higher technological content to provide customers.
  
  The company will, as always, position itself in "service technology, professionalism and efficiency, and achieve customers", and work hard to jointly shape the IVD industry and continuously improve the level of human health.
  
  Construction area 15,000+ m²
  
  Workshop standard 100,000-level and 10,000-level purification workshops
  
  Production Capacity 40,000+ Pcs/Month
  
  Output Value ￥130+ million/year
  
  Registered Products 100+
  
  Cooperative Hospital 340+
  
  Researchers 30+
  
  Certificates 150+
  
  Working Experience 20 years+